A retrospective study to evaluate effectiveness of ceftazidime-avibactam in a tertiary hospital of Spain
Latest Information Update: 25 Jun 2020
Price :
$35 *
At a glance
- Drugs Avibactam/ceftazidime (Primary)
- Indications Intra-abdominal infections; Respiratory tract infections; Septicaemia; Urinary tract infections
- Focus Therapeutic Use
- 25 Jun 2020 New trial record